Home » FRANCE'S INNATE PHARMA SIGNS DEAL WITH SCHERING-PLOUGH
FRANCE'S INNATE PHARMA SIGNS DEAL WITH SCHERING-PLOUGH
Privately held French biotech company Innate Pharma on Monday said it has signed a deal with U.S.-based Schering-Plough Corp. (SGP) to in-license some assets for developing toll-like receptors, or TLRs, which can help activate the body's adaptive immune system.
Market
Watch
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May